Article info

Download PDFPDF
Extended report
A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon

Authors

  1. Correspondence to Dr Laura Kathleen Hummers, Division of Rheumatology, Johns Hopkins University, 5501 Hopkins Bayview Circle, Baltimore, MD 21224, USA; lhummers{at}jhmi.edu
View Full Text

Citation

Hummers LK, Dugowson CE, Dechow FJ, et al
A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon

Publication history

  • Received February 16, 2012
  • Revised November 1, 2012
  • Accepted November 18, 2012
  • First published December 25, 2012.
Online issue publication 
November 04, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.